Long-term survival in patients with pancreatic cancer (PAC) treated with liposomal irinotecan in combination with 5-fluorouracil and leucovorin (nal-IRI+5-FU/LV)-MedSci.cn

Long-term survival in patients with pancreatic cancer (PAC) treated with liposomal irinotecan in combination with 5-fluorouracil and leucovorin (nal-IRI+5-FU/LV)

Prager, G; Potthoff, K; Yoo, C; Lonardi, S; Hedouin-Biville, F; Macarulla, T

ANNALS OF ONCOLOGY, 2022; 33 (): S248

科室
- - 订阅+
  - 更多科室
工具
服务